<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="Abstract Background Commercially available antiviral drugs, when used in the" exact="treatment" post="of viral infections, do not always result in success."/>
 <result pre="these selected extracts was tested by checking their effect on" exact="hemagglutination" post="and neuraminidase activities of the studied viruses. Additionally, actinomycetes"/>
 <result pre="suitable for a good pharmacological response when applied in the" exact="treatment" post="of infections. There is also cost-effectiveness and cost-benefit issue"/>
 <result pre="(104 cells/well) was estimated by the method of dehydrogenases activity" exact="detection" post="(MTT-test), which is based on the ability of dehydrogenases"/>
 <result pre="parameter for calculating the toxicity of the tested samples. Antiviral" exact="testing" post="of Actinomycetes Antiviral analysis was done to test the"/>
 <result pre="to test the activity of the studied actinomycetes extracts on" exact="hemagglutination" post="and neuraminidase activity of selected viruses. The action on"/>
 <result pre="and neuraminidase activity of selected viruses. The action on the" exact="hemagglutination" post="activity was tested using influenza viruses (strains H7N1, H5N3,"/>
 <result pre="Flavovir) and commercial antiviral drugs (Rimantadine and Tamiflu). Effect on" exact="hemagglutination" post="activity The following strains of viruses were grown in"/>
 <result pre="tested samples were mixed with equal volume of viruses with" exact="hemagglutination" post="titer of 1:256. After 30 min incubation at 37 °C, hemagglutination"/>
 <result pre="with hemagglutination titer of 1:256. After 30 min incubation at 37 °C," exact="hemagglutination" post="activity was determined by a standard method using 0.75%"/>
 <result pre="was used. Hemagglutination inhibition activity was calculated by comparison of" exact="hemagglutination" post="titers in a control and tested sample. Effect on"/>
 <result pre="strains of orthomyxoviruses and paramyxoviruses were used in neuraminidase activity" exact="tests" post="as in hemagglutination activity analysis. Also, the following reagents"/>
 <result pre="and paramyxoviruses were used in neuraminidase activity tests as in" exact="hemagglutination" post="activity analysis. Also, the following reagents were used: enzyme"/>
 <result pre="strain. The presence of the viruses was indicated by the" exact="hemagglutination" post="test (HA-test). The ability of investigated preparations to inhibit"/>
 <result pre="plant preparations In addition, the same procedure as in the" exact="testing" post="of the effect of virus-inhibitory activity was applied using"/>
 <result pre="The mean values (TC50) for the results of hemolytic activity" exact="testing" post="were analyzed by Kruskal-Wallis rank test using the STATA"/>
 <result pre="STATA 13 software. The actions of extract preparations on the" exact="hemagglutination" post="activity of test-viruses were calculated based on the average"/>
 <result pre="extract preparations (EIC50, mg/ml) capable of inhibiting 50% of viral" exact="hemagglutination" post="activity (HI50). The same calculation procedure was applied to"/>
 <result pre="actinomycetes strain biomass (cells) in saline conditions of growth. Toxicity" exact="testing" post="of Actinomycetes preparations Toxicity of the 30 preparations described"/>
 <result pre="40 28.57 33.3 2 14.29 Effect of actinomycetes preparations on" exact="hemagglutination" post="activity of selected influenza and paramyxoviruses The influence of"/>
 <result pre="extracts, culture broth extracts, and cell-free culture media) on the" exact="hemagglutination" post="activity of orthomyxoviruses (influenza viruses strains H7N1, H5N3, H1N1,"/>
 <result pre="Sendai virus) was studied. The effects of preparations on the" exact="hemagglutination" post="activity of test-viruses were calculated to determine effective inhibition"/>
 <result pre="concentration of preparation (EIC50, mg/ml) that inhibited 50% of viral" exact="hemagglutination" post="activity. We determined that most of the extremophiles actinomycetes"/>
 <result pre="that most of the extremophiles actinomycetes preparations did not inhibit" exact="hemagglutination" post="activity of most of the tested influenza viruses (strains"/>
 <result pre="1a and Fig. 1, several preparations were found to inhibit" exact="hemagglutination" post="activity of influenza virus H1N1. Fig. 1 a The"/>
 <result pre="H1N1. Fig. 1 a The effect of preparations on the" exact="hemagglutination" post="inhibition (HI mean, mg/ml) of influenza virus H1N1. Tested"/>
 <result pre="Tested samples were mixed with equal volume of viruses with" exact="hemagglutination" post="titer of 1:256. After 30 min incubation at 37 °C, hemagglutination"/>
 <result pre="with hemagglutination titer of 1:256. After 30 min incubation at 37 °C," exact="hemagglutination" post="activity was determined by a standard method [2, 4]."/>
 <result pre="[2, 4]. Hemagglutination inhibition activity was calculated by comparison of" exact="hemagglutination" post="titers in the control and tested sample. b Effective"/>
 <result pre="influenza virus H1N1 The quantitative measurement of specific inhibition of" exact="hemagglutination" post="activity in influenza virus H1N1 by preparations from 5"/>
 <result pre="actinomycetes is indicated by mean and standard deviation measures of" exact="hemagglutination" post="inhibition (HI) of the H1N1 virus (Fig. 1a). Thus,"/>
 <result pre="preparations (and thus more effective) to induce inhibition of the" exact="hemagglutination" post="activity of the H1N1. Culture broth preparations CBN and"/>
 <result pre="K-340, K-522 and K-525 showed more effective inhibitory effects on" exact="hemagglutination" post="activity. Comparing extracts prepared from culture broths of strains"/>
 <result pre="saline conditions that were effective in inhibiting 50% of the" exact="hemagglutination" post="activity of the influenza virus H1N1. K-525-2S exhibited the"/>
 <result pre="to the other 5 selected preparations that inhibited 50% of" exact="hemagglutination" post="activity of influenza virus H1N1. Effect of actinomycetes preparations"/>
 <result pre="strain. The presence of the viruses was indicated by the" exact="hemagglutination" post="test (HA-test). The ability of investigated preparations to inhibit"/>
 <result pre="viruses displaying antiviral SI values higher than those obtained by" exact="testing" post="with the commercially available drugs Tamiflu and Rimantidine. In"/>
 <result pre="with the extracts of actinomycetes biomass. The results of toxicity" exact="testing" post="which were found not to be significantly different based"/>
 <result pre="antiviral compounds described in this study are novel. Hemagglutination activity" exact="testing" post="showed inhibition of only one influenza virus strain- H1N1."/>
 <result pre="2 N preparations in K-362 and K-525 was required to inhibit" exact="hemagglutination" post="activity, thus indicating high effectiveness. However, the CBS preparations"/>
 <result pre="preparations of the most strains showed less effectiveness in inhibiting" exact="hemagglutination" post="activity of H1N1. The K-192-1 N, K-192-2 N, and K-192-2S extracts"/>
 <result pre="can be further characterized to produce therapeutically effective antivirals for" exact="treatment" post="of infections caused by our tested viral strains. As"/>
 <result pre="the antiviral mechanism of actions. Since this is a preliminary" exact="screening" post="study of selected extracts from our collection, it represents"/>
 <result pre="actinomycetes that can be considered as a promising source for" exact="isolation" post="and study of compounds that can block the reproduction"/>
 <result pre="of influenza virus type A. Future studies will focus on" exact="isolation" post="and characterization of active compounds responsible for the antiviral"/>
 <result pre="virus-inhibiting concentration HI50 concentration of substance that induced 50% of" exact="hemagglutination" post="inhibition NI50 concentration of substance that induced 50% of"/>
 <result pre="Vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus" exact="infection" post="and hemagglutinationVirology Journal20107130710.1186/1743-422X-7-30721062499 4.PalesePeterInfluenza: old and new threatsNature Medicine200410S12S82S8710.1038/nm1141"/>
 <result pre="20.Li AF, Wang WH, Xu WF, Gong JZ. A microplate-based" exact="screening" post="assay for neuraminidase inhibitors. Drug Discov Ther. 2009;3(6):260–5. 21.Guidelines"/>
</results>
